Detalles de la búsqueda
1.
The wonders of 2-deoxy-D-glucose.
IUBMB Life
; 66(2): 110-21, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24578297
2.
Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1-expressing myeloma cells.
Blood
; 118(5): 1329-39, 2011 Aug 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-21659544
3.
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study.
Lancet Neurol
; 22(7): 578-590, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37353278
4.
Activation of the unfolded protein response by 2-deoxy-D-glucose inhibits Kaposi's sarcoma-associated herpesvirus replication and gene expression.
Antimicrob Agents Chemother
; 56(11): 5794-803, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22926574
5.
Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma.
Leukemia
; 35(3): 752-763, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32632095
6.
Global variability of the human IgG glycome.
Aging (Albany NY)
; 12(15): 15222-15259, 2020 08 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32788422
7.
Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines.
Mol Cancer Ther
; 7(6): 1506-13, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18566221
8.
Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.
Mol Cancer Ther
; 6(2): 732-41, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17308069
9.
Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation.
Mol Cancer Ther
; 6(11): 3049-58, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18025288
10.
Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells.
Antioxid Redox Signal
; 9(9): 1383-90, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17627467
11.
Efficacy of 2-halogen substituted D-glucose analogs in blocking glycolysis and killing "hypoxic tumor cells".
Cancer Chemother Pharmacol
; 58(6): 725-34, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16555088
12.
The role of hypoxia in pancreatic cancer: a potential therapeutic target?
Expert Rev Gastroenterol Hepatol
; 10(3): 301-16, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26560854
13.
Combining 2-deoxy-D-glucose with fenofibrate leads to tumor cell death mediated by simultaneous induction of energy and ER stress.
Oncotarget
; 7(24): 36461-36473, 2016 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-27183907
14.
Elevating the Horizon: Emerging Molecular and Genomic Targets in the Treatment of Advanced Urothelial Carcinoma.
Clin Genitourin Cancer
; 13(5): 410-20, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25862322
15.
Identification of active chemotherapy regimens in advanced biliary tract carcinoma: a review of chemotherapy trials in the past two decades.
Hepat Oncol
; 2(1): 39-50, 2015 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25685318
16.
[Venous thromboembolism prophylaxis with low molecular weight heparins in polytraumatized patients in intensive care unit (extended serie)]. / Politravmatize yogun bakim hastalarinda düsük molekül agirlikli heparin ile venöz tromboembolizm profilaksisi (genisletilmis seri).
Ulus Travma Acil Cerrahi Derg
; 9(1): 37-44, 2003 Jan.
Artículo
en Turco
| MEDLINE | ID: mdl-12587053
17.
Targeting cisplatin-resistant human tumor cells with metabolic inhibitors.
Cancer Chemother Pharmacol
; 73(2): 417-27, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24352250
18.
Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose.
Cancer Chemother Pharmacol
; 73(2): 349-61, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24292700
19.
Conversion of 2-deoxyglucose-induced growth inhibition to cell death in normoxic tumor cells.
Cancer Chemother Pharmacol
; 72(1): 251-62, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23700291
20.
A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors.
Cancer Chemother Pharmacol
; 71(2): 523-30, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23228990